These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11905511)

  • 1. Lipid-lowering drugs (statins), cholesterol, and coenzyme Q10. The Baycol case--a modern Pandora's box.
    Bliznakov EG
    Biomed Pharmacother; 2002 Feb; 56(1):56-9. PubMed ID: 11905511
    [No Abstract]   [Full Text] [Related]  

  • 2. HMG-CoA reductase inhibitors and coenzyme Q10.
    Nawarskas JJ
    Cardiol Rev; 2005; 13(2):76-9. PubMed ID: 15705257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statins and their side effects. Some evidence suggests coenzyme Q10 might help with muscle problems, but it's too early to recommend it.
    Harv Health Lett; 2005 Jun; 30(8):4. PubMed ID: 16136675
    [No Abstract]   [Full Text] [Related]  

  • 4. Potential role of coenzyme Q10 in facilitating recovery from statin-induced rhabdomyolysis.
    Wang LW; Jabbour A; Hayward CS; Furlong TJ; Girgis L; Macdonald PS; Keogh AM
    Intern Med J; 2015 Apr; 45(4):451-3. PubMed ID: 25827512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bayer pulls cerivastatin (Baycol) from market.
    Wooltorton E
    CMAJ; 2001 Sep; 165(5):632. PubMed ID: 11563216
    [No Abstract]   [Full Text] [Related]  

  • 6. Baycol withdrawn from market.
    SoRelle R
    Circulation; 2001 Aug; 104(8):E9015-6. PubMed ID: 11521677
    [No Abstract]   [Full Text] [Related]  

  • 7. Bayer voluntarily withdraws Baycol.
    AWHONN Lifelines; 2001; 5(5):21. PubMed ID: 11982285
    [No Abstract]   [Full Text] [Related]  

  • 8. [Rhabdomyolysis following cerivastatin monotherapy--implications for therapy with HMG-CoA reductase inhibitors].
    Sparing R; Sellhaus B; Noth J; Block F
    Nervenarzt; 2003 Feb; 74(2):167-71. PubMed ID: 12596018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statins, coenzyme Q10, and cachexia: what's the link?
    Molfino A; Costelli P; Aversa Z; Baccino FM; Rossi Fanelli F; Muscaritoli M
    Am J Cardiol; 2007 Nov; 100(9):1497-8. PubMed ID: 17950821
    [No Abstract]   [Full Text] [Related]  

  • 10. Statins and myopathy.
    Hargreaves IP; Heales S
    Lancet; 2002 Feb; 359(9307):711-2. PubMed ID: 11879898
    [No Abstract]   [Full Text] [Related]  

  • 11. Cerivastatin and reports of fatal rhabdomyolysis.
    Staffa JA; Chang J; Green L
    N Engl J Med; 2002 Feb; 346(7):539-40. PubMed ID: 11844864
    [No Abstract]   [Full Text] [Related]  

  • 12. Baycol: take-home messages about medications.
    Harv Heart Lett; 2001 Oct; 12(2):2-3. PubMed ID: 11684487
    [No Abstract]   [Full Text] [Related]  

  • 13. Substituting for cerivastatin (Baycol).
    Med Lett Drugs Ther; 2001 Sep; 43(1113):79-80. PubMed ID: 11581579
    [No Abstract]   [Full Text] [Related]  

  • 14. Statins and coenzyme Q10.
    Ellis CJ; Scott R
    Lancet; 2003 Mar; 361(9363):1134-5. PubMed ID: 12672343
    [No Abstract]   [Full Text] [Related]  

  • 15. Considerations for supplementing with coenzyme Q10 during statin therapy.
    Levy HB; Kohlhaas HK
    Ann Pharmacother; 2006 Feb; 40(2):290-4. PubMed ID: 16449543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The withdrawal of Baycol (cerivastatin).
    Griffin JP
    Adverse Drug React Toxicol Rev; 2001 Dec; 20(4):177-80. PubMed ID: 11770168
    [No Abstract]   [Full Text] [Related]  

  • 17. Antioxidants decreases the intensification of low density lipoprotein in vivo peroxidation during therapy with statins.
    Lankin VZ; Tikhaze AK; Kukharchuk VV; Konovalova GG; Pisarenko OI; Kaminnyi AI; Shumaev KB; Belenkov YN
    Mol Cell Biochem; 2003 Jul; 249(1-2):129-40. PubMed ID: 12956408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of coenzyme q10 on myopathic symptoms in patients treated with statins.
    Caso G; Kelly P; McNurlan MA; Lawson WE
    Am J Cardiol; 2007 May; 99(10):1409-12. PubMed ID: 17493470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical use of HMG CoA-reductase inhibitors and the associated depletion of coenzyme Q10. A review of animal and human publications.
    Langsjoen PH; Langsjoen AM
    Biofactors; 2003; 18(1-4):101-11. PubMed ID: 14695925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case reports of rhabdomyolysis associated with cerivastatin therapy.
    Simpson S
    Arch Intern Med; 2001 Nov; 161(21):2630-1. PubMed ID: 11718617
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.